FDA Adverse Event Injury Summary report: N

M2A-T UNIV 2-HOLE SHL SZ 41/54

MDR report key: 8809894 · Received July 20, 2019

Report

Report Number
0001825034-2018-04297
Event Type
Injury
Date Received
July 20, 2019
Date of Event
April 19, 2017
Report Date
August 5, 2019
Manufacturer
ZIMMER BIOMET, INC.
Product Code
KWA
PMA / PMN Number
K003363
Removal / Correction Number
N/A
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
VA, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 0

IT WAS DETERMINED THIS DEVICE DID NOT CAUSE OR CONTRIBUTE TO THE REPORTED EVENT. PLEASE VOID THIS SUBMISSION.

Description of Event or Problem · 0

IT WAS DETERMINED THIS DEVICE DID NOT CAUSE OR CONTRIBUTE TO THE REPORTED EVENT. PLEASE VOID THIS SUBMISSION.

Additional Manufacturer Narrative · 1

(B)(4). CONCOMITANT MEDICAL PRODUCTS: 15-105044, M2A TPR HI CARBON 41/32MM LNR, 912570. X11-180312, BI-METRIC/X POR NC LAT 12X140, 774930. 11-163688, 32MM M2A HI CARBON HD STD NK, 767120. MULTIPLE MDR REPORTS WERE FILED FOR THIS EVENT, PLEASE SEE ASSOCIATED REPORTS: 0001825034 - 2018 - 04296, 0001825034 - 2018 - 04298. IF ANY FURTHER INFORMATION IS FOUND WHICH WOULD CHANGE OR ALTER ANY CONCLUSIONS OR INFORMATION, A SUPPLEMENTAL WILL BE FILED ACCORDINGLY. ZIMMER BIOMET WILL CONTINUE TO MONITOR FOR TRENDS.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT REVISION SURGERY APPROXIMATELY 9 YEARS POST INITIAL SURGERY DUE TO PAIN, LIMITED RANGE OF MOTION, METALLOSIS, PSEUDOTUMOR AND BONE EROSION. DURING THE SURGERY IT WAS FOUND THAT ANTERIOR CAPSULE HAD SIGNIFICANT METALLOSIS REACTION AND STAINING IN THE TISSUE. RADICAL RESECTION REMOVING THE ENTIRE ANTERIOR AND AS MUCH OF THE INFERIOR AND SUPERIOR CAPSULE. THERE WAS SIGNIFICANT METALLOSIS REACTION AROUND THE ACETABULAR IMPLANT WITH SIGNIFICANT SOFTENING AND BONE LOSS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
603636 M2A-T UNIV 2-HOLE SHL SZ 41/54 PROSTHESIS, HIP KWA ZIMMER BIOMET, INC. N/A 801490

Patients

Seq Age Sex Outcome Treatment
1 Hospitalization| R